Search
GWAS ID | Year | Trait | Consortium | Sample size | Number of SNPs |
---|---|---|---|---|---|
ebi-a-GCST011086 | 2020 | COVID-19 (hospitalized vs not hospitalized) RELEASE 5 | NA | 170 | 7,645,005 |
ebi-a-GCST90011798 | 2021 | Etoposide drug response (IC50) | NA | 171 | 9,501,543 |
ebi-a-GCST90011795 | 2021 | Carboplatin drug response (IC50) | NA | 172 | 9,508,434 |
ebi-a-GCST90011797 | 2021 | Daunorubicin drug response (IC50) | NA | 173 | 9,513,392 |
ebi-a-GCST006363 | 2018 | Anti-Helicobacter pylori IgG levels | NA | 175 | 5,278,042 |
Data overview
The GWAS summary datasets are currently organised into the following 18 batches: